Cite
MLA Citation
Andrea Visentin et al.. “Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.” American journal of hematology, vol. 97, no. 3, 2022, pp. E95–E99. http://access.bl.uk/ark:/81055/vdc_100150587321.0x000041